Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

FDA authorizes Pfizer's COVID-19 vaccine booster for U.S. adults

Published 11/19/2021, 08:32 AM
Updated 11/19/2021, 08:35 AM
© Reuters. FILE PHOTO: A health worker draws a dose of Pfizer-BioNTech coronavirus disease (COVID-19) vaccine from a vial during a vaccination event hosted by Miami - Dade County and Miami Heat, at FTX Arena in Miami, Florida, U.S., August 5, 2021. REUTERS/Marco Bel
PFE
-
MRNA
-
BNTX
-

(Reuters) - The U.S. Food and Drug Administration on Friday authorized booster doses of Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX)'s COVID-19 vaccine for all adults, a move aimed at addressing waning protection among fully vaccinated Americans in the face of Delta variant-driven breakthrough cases of the illness.

Earlier in the day, Moderna (NASDAQ:MRNA) said the FDA extended the emergency use authorization of a booster dose of its COVID-19 vaccine to all adults aged 18 and older.

A U.S. Centers for Disease Control and Prevention advisory panel is expected to meet later in the day to discuss whether to recommend the booster doses for the broader population.

Latest comments

biggest sham ever perpetrated on the world. the complicity, ignorance and fear is astounding
could anyone advise me, if the variance of a stock did not diviated e.g 1.35 previously and now is still 1.35 how do I know if an asset is risky or riskless in this regard?
Welcome to the United States of Pharmaceuticals (USP)
what a joke
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.